Cargando…

JAK inhibitors for refractory lymphoma

Detalles Bibliográficos
Autor principal: Kimura, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152482/
https://www.ncbi.nlm.nih.gov/pubmed/30250636
http://dx.doi.org/10.18632/oncotarget.26054
_version_ 1783357374421008384
author Kimura, Hiroshi
author_facet Kimura, Hiroshi
author_sort Kimura, Hiroshi
collection PubMed
description
format Online
Article
Text
id pubmed-6152482
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-61524822018-09-24 JAK inhibitors for refractory lymphoma Kimura, Hiroshi Oncotarget News Impact Journals LLC 2018-08-31 /pmc/articles/PMC6152482/ /pubmed/30250636 http://dx.doi.org/10.18632/oncotarget.26054 Text en Copyright: © 2018 Kimura http://creativecommons.org/licenses/by/3.0/ This article is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/) (CC-BY), which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle News
Kimura, Hiroshi
JAK inhibitors for refractory lymphoma
title JAK inhibitors for refractory lymphoma
title_full JAK inhibitors for refractory lymphoma
title_fullStr JAK inhibitors for refractory lymphoma
title_full_unstemmed JAK inhibitors for refractory lymphoma
title_short JAK inhibitors for refractory lymphoma
title_sort jak inhibitors for refractory lymphoma
topic News
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6152482/
https://www.ncbi.nlm.nih.gov/pubmed/30250636
http://dx.doi.org/10.18632/oncotarget.26054
work_keys_str_mv AT kimurahiroshi jakinhibitorsforrefractorylymphoma